Topical Collagenase (Santyl) Drug Quantity Management
Cigna drug quantity management policy governing maximum per-prescription quantities and coverage criteria for Santyl (collagenase santyl ointment 250 units/gram) for health benefit plans administered by Cigna companies; includes retail and home delivery quantity limits, approval criteria, exclusions, and review dates.
Annual Revision, Review Date = 10/02/2024; summary indicates No criteria changes.
Prior annual revision review date = 09/27/2023; No criteria changes.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.